Health Catalyst CEO disposes shares for RSU taxes

Health Catalyst, Inc. CEO Albert Benjamin reported a Form 4 transaction involving common stock.

Accepted by SEC EDGAR 03/05/2026 - 06:48 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Health Catalyst, Inc. CEO Albert Benjamin reported a Form 4 transaction involving common stock. On March 2, 2026, he disposed of 4,966 shares of common stock at $1.6599 per share as a tax-withholding disposition related to vesting of restricted stock units. This sale was mandated under the company’s equity incentive plan as a “sell to cover” transaction and was not a discretionary trade. Following this transaction, he directly owned 1,528,433 shares of common stock.

Insider Trade Summary

Exercise Price or Tax Liability: 4,966 shares

Exercise Price or Tax Liability 1 txn

Insider Albert Benjamin

Role CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	4,966	$1.6599	$8K

Holdings After Transaction: Common Stock — 1,528,433 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Health Catalyst (HCAT) report for its CEO?

Health Catalyst CEO Albert Benjamin reported a Form 4 tax-related share disposition. He transferred 4,966 shares of common stock on March 2, 2026 to satisfy withholding taxes owed on vesting restricted stock units under the company’s equity incentive plans.

How many Health Catalyst (HCAT) shares did the CEO dispose of and at what price?

Albert Benjamin disposed of 4,966 Health Catalyst common shares at $1.6599 per share. The transaction was coded as a tax-withholding disposition, meaning shares were used to cover RSU-related tax obligations rather than an open-market discretionary sale.

Why did the Health Catalyst (HCAT) CEO’s Form 4 show a share sale?

The Form 4 shows a sale because shares were used to cover tax withholding obligations tied to vesting restricted stock units. The footnote states this “sell to cover” transaction was mandated by the company’s equity plans and does not represent a discretionary trade by the CEO.

How many Health Catalyst (HCAT) shares does the CEO hold after this transaction?

After the tax-withholding disposition, CEO Albert Benjamin directly held 1,528,433 shares of Health Catalyst common stock. This figure reflects his ownership immediately following the 4,966-share “sell to cover” transaction reported for March 2, 2026.

What does transaction code F mean in the Health Catalyst (HCAT) CEO Form 4?

Transaction code F indicates shares were disposed of to pay an exercise price or tax liability. Here, it reflects a tax-withholding disposition, where 4,966 shares were sold to satisfy RSU-related taxes under the company’s equity incentive plans, not a discretionary market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albert Benjamin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		F(1)		4,966	D	$1.6599	1,528,433	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.